A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin

Molecular and Cellular Biology

Volumn 24, Issue 7, 2004, Pages 2986-2997

  Browne, Gareth J ^a   Proud, Christopher G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CALMODULIN BINDING PROTEIN; ELONGATION FACTOR 2 KINASE; INSULIN; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE; RAPAMYCIN; S6 KINASE; SERINE; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

ADENOSINE TRIPHOSPHATE; AMINO ACIDS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALMODULIN; CELL LINE; CRICETINAE; HUMANS; INSULIN; MICE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SERINE; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; EUKARYOTA;

EID: 1642355123     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.7.2986-2997.2004     Document Type: Article

References (52)

1. Alessi, D. R. 1997. The protein kinase C inhibitors Ro31-8220 and GF109203X are equally potent inhibitors of MAPKAP kinase-1β and p70 S6 kinase. FEBS Lett. 402:121-123.
2. Alessi, D. R., M. T. Kozlowski, Q.-P. Weng, N. Morrice, and J. Avruch. 1998. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8:69-81.
3. Aoki, M., E. Blazek, and P. K. Vogt. 2001. A role for the kinase mTOR in cellular transformation induced by the oncoproteins P3K and Akt. Proc. Natl. Acad. Sci. USA 98:136-141.
4. Avruch, J., C. Belham, Q. Weng, K. Hara, and K. Yonezawa. 2001. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26:115-154.
5. Balendran, A., G. R. Hare, A. Kieloch, M. R. Williams, and D. R. Alessi. 2000. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett. 484:217-223.
6. Beauloye, C., A. S. Marsin, L. Bertrand, U. Krause, D. G. Hardie, J. L. Vanoverschelde, and L. Hue. 2001. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett. 505:348-352.
7. Beugnet, A., A. R. Tee, P. M. Taylor, and C. G. Proud. 2002. Evidence that intracellular amino acids regulate translation factor function in mammalian cells. Biochem. J. 372:555-566.
8. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 77:248-254.
9. Browne, G. J., S. G. Finn, and C. G. Proud. 5 January 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. http://www.jbc.org/cgi/reprint/M309773200vl.
10. Browne, G. J., and C. G. Proud. 2002. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269:5360-5368.
11. Campbell, L. E., X. Wang, and C. G. Proud. 1999. Nutrients differentially modulate multiple translation factors and their control by insulin. Biochem. J. 344:433-441.
12. Carlberg, U., A. Nilsson, and O. Nygard. 1990. Functional properties of phosphorylated elongation factor 2. Eur. J. Biochem. 191:639-645.
13. Choi, K.-M., L. P. McMahon, and J. C. Lawrence. 2003. Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor. J. Biol. Chem. 278:19667-19673.
14. Cohen, P., D. R. Alessi, and D. A. E. Cross. 1997. PDK1, one of the missing links in insulin signal transduction? FEBS Lett. 410:3-10.
15. Dennis, P. B., A. Jaeschke, M. Saitoh, B. Fowler, S. C. Kozma, and G. Thomas. 2001. Mammalian TOR: a homeostatic ATP sensor. Science 294: 1102-1105.
16. Diggle, T. A., C. K. Seehra, S. Hase, and N. T. Redpath. 1999. Analysis of the domain structure of elongation factor-2 kinase by mutagenesis. FEBS Lett. 457:189-192.
17. 2+/calmodulin-independent activity. Biochem. J. 353:621-626.
18. Dutil, E. M., A. Toker, and A. C. Newton. 1998. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8:1366-1375.
19. Everett, A. D., T. D. Stoops, A. C. Nairn, and D. Brautigan. 2001. Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes. Am. J. Physiol. 281:H161-H167.
20. Fingar, D. C., S. Salama, C. Tsou, E. Harlow, and J. Blenis. 2002. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:1472-1487.
21. Gingras, A.-C., B. Raught, and N. Sonenberg. 2001. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27:143-174.
22. Hara, K., K. Yonezawa, Q.-P. Weng, M. T. Kozlowski, C. Belham, and J. Avruch. 1998. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF4E BP1 through a common effector mechanism. J. Biol. Chem. 273: 14484-14494.
23. Horman, S., G. J. Browne, U. Krause, J. V. Patel, D. Vertommen, L. Bertrand, A. Lavoinne, L. Hue, C. G. Proud, and M. H. Rider. 2002. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12:1419-1423.
24. Jaeschke, A., J. Hartkamp, M. Saitoh, W. Roworth, T. Nobukuni, A. Hodges, J. Sampson, G. Thomas, and R. Lamb. 2002. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159:217-224.
25. Knebel, A., C. E. Haydon, N. Morrice, and P. Cohen. 2002. Stress-induced regulation of eEF2 kinase by SB203580-sensitive and -insensitive pathways. Biochem. J. 367:525-532.
26. Knebel, A., N. Morrice, and P. Cohen. 2001. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20:4360-4369.
27. Le Good, J. A., W. H. Ziegler, D. B. Parekh, D. R. Alessi, P. Cohen, and P. J. Parker. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042-2045.
28. Manning, B. D., and L. C. Cantley. 2003. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28:573-576.
29. McLeod, L. E., L. Wang, and C. G. Proud. 2001. β-Adrenergic agonists increase phosphorylation of elongation factor 2 in cardiomyocytes without eliciting calcium-independent eEF2 kinase activity. FEBS Lett. 489:225-228.
30. McManus, E. J., and D. R. Alessi. 2002. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat. Cell Biol. 4:E214-E216.
31. Neshat, M. S., I. K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J. J. Gibbons, H. Wu, and C. L. Sawyers. 2001. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA 98:10314-10319.
32. Nojima, H., C. Tokunaga, S. Eguchi, N. Oshiro, S. Hidayat, K. Yoshino, K. Hara, J. Tanaka, J. Avruch, and K. Yonezawa. 2003. The mTOR partner, raptor, binds the mTOR substrates, p70 S6 kinase and 4E-BP1, through their TOS (TOR signaling) motifs. J. Biol. Chem. 278:15461-15464.
33. Parekh, D., W. Ziegler, K. Yonezawa, K. Hara, and P. J. Parker. 1999. Mammalian TOR controls one of two kinase pathways acting upon PKC-delta and epsilon. J. Biol. Chem. 274:34758-34764.
34. Pavur, K. S., A. N. Petrov, and A. G. Ryazanov. 2000. Mapping the functional domains of elongation factor-2 kinase. Biochemistry 39:12216-12224.
35. S6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14:5279-5287.
36. Price, N. T., S. F. Nakielny, S. J. Clark, and C. G. Proud. 1989. The two forms of the beta-subunit of initiation factor-2 from reticulocyte lysates arise from proteolytic degradation. Biochim. Biophys. Acta 1008:177-182.
37. Proud, C. G. 2002. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269:5338-5349.
38. S6k by PDK1. Science 279:707-710.
39. Ravikumar, B., A. Stewart, H. Kita, K. Kato, R. Duden, and D. C. Rubinsztein. 2003. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. Hum. Mol. Genet. 12:985-994.
40. Redpath, N. T., E. J. Foulstone, and C. G. Proud. 1996. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 15:2291-2297.
41. Ryazanov, A. G., M. D. Ward, C. E. Mendola, K. S. Pavur, M. V. Dorovkov, M. Wiedmann, H. Erdjument-Bromage, P. Tempst, T. G. Parmer, C. R. Prostko, F. J. Germino, and W. N. Hait. 1997. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc. Natl. Acad. Sci. USA 94:4884-4889.
42. Schalm, S. S., and J. Blenis. 2002. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12:632-639.
43. Schalm, S. S., D. C. Fingar, D. M. Sabatini, and J. Blenis. 2003. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13:797-806.
44. S6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:6649-6659.
45. Takano, A., I. Usui, T. Haruta, J. Kawahara, T. Uno, M. Iwata, and M. Kobayashi. 2001. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptors substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 21:5050-5062.
46. Vanhaesebroeck, B., and D. R. Alessi. 2000. The P13K-PDK1 connection: more than just a road to PKB. Biochem. J. 346:561-576.
47. Wang, L., and C. G. Proud. 2002. Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes. FEBS Lett. 531:285-289.
48. Wang, L., X. Wang, and C. G. Proud. 2000. Activation of mRNA translation by insulin in rat cardiomyocytes involves multiple rapamycin-sensitive steps. Am. J. Physiol. 278:H1056-H1068.
49. Wang, X., L. E. Campbell, C. M. Miller, and C. G. Proud. 1998. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334:261-267.
50. RSK1 and p70 S6 kinase. EMBO J. 20:4370-4379.
51. Williams, M. R., J. S. C. Arthur, A. Balendran, J. van der Kaay, V. Poli, P. Cohen, and D. R. Alessi. 2000. Role of PDK1 in mediating the activation of AGC kinases in embryonic stem cells defined by targeted disruption of the PDK1 gene. Curr. Biol. 20:439-448.
52. Zhang, H., G. Cicchetti, H. Onda, H. B. Koon, K. Asrican, N. Bajraszewski, F. Vazquez, C. L. Carpenter, and D. J. Kwiatkowski. 2003. Loss of Tsc1/Tse2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Investig. 112:1223-1233.